Related Experiment Video
Updated: Jul 14, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Aggressive statin therapy for acute coronary syndromes
1Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK.
Statins, or HMG CoA reductase inhibitors, are effective in treating acute coronary syndromes (ACS). This article reviews emerging evidence on their use in managing ACS patients, who face a high risk of recurrent events.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute coronary syndromes (ACS) represent a significant global health burden.
- Despite advances in conventional therapy, patients with ACS remain at high risk for recurrent events.
Purpose of the Study:
- To examine the emerging evidence for the efficacy of statins in the treatment of acute coronary syndromes (ACS).
Main Methods:
- Review of a substantial body of evidence regarding statin therapy in ACS.
Main Results:
- Statins are well-established for primary and secondary prevention of stable coronary heart disease.
- Recent evidence demonstrates statins' effectiveness in treating ACS.
Conclusions:
- Statins show proven efficacy in managing acute coronary syndromes.
- This review highlights the growing role of statins in ACS treatment.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies